graphic
graphic  

graphic
    Home

    News 

 companies
 company research
 deals
 economy
 financial news in brief
 industry watch
 international
 
    Markets & Stocks

    Commentary

    Technology

    Personal Finance

    Retirement

    Mutual Funds

    Money 101

    Money's Best

Track your stocks

Calculators

  CNN on TV
  Watch CNN video
  Buy show videos

  Services

  CNN.com

  CNNSI.com

  MONEY Magazine
  Customer Service


  E-MAIL
  NEWSLETTERS
  sign up!

  MOBILE NEWS
  •AvantGo
  sign up!

 graphic
News > Companies
graphic
Amgen arthritis drug OK'd
graphic November 14, 2001: 2:11 p.m. ET

FDA approves Kineret, Amgen's new treatment for rheumatoid arthritis.
graphic
graphic graphic
graphic
graphic
graphic       graphic
  • Amgen
    •  
    graphic
    NEW YORK (CNN/Money) - The U.S. Food and Drug Administration, as expected, has approved Amgen Inc.'s new treatment for rheumatoid arthritis, which could help up to 300,000 patients.

    Amgen said Wednesday the FDA approved Kineret "for the reduction in signs and symptoms of moderately to severely active rheumatoid arthritis in adult patients who have failed one or more disease modifying antirheumatic drugs."

    Kineret has a novel mechanism that selectively and directly blocks a certain protein associated with inflammation and arthritis.

    An FDA advisory panel voted in favor of approval in August, and the FDA usually follows the advice of the pane.

    "Kineret worked for many of my patients," said Dr. Stanley Cohen, a clinical investigator for the drug's trails, in an Amgen statement. "I am impressed with the improvements in my patients' painful and swollen joints." graphic

      RELATED LINKS

    Amgen




    		  graphic
    © 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy. Advertising Practices.
    Live Quotes automatically refresh, but individual equities are delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.
    * : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
    Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
    MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
    Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
    Intraday data is at least 20-minutes delayed. All times are ET.
    Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
    Fundamental data provided by Morningstar, Inc..
    SEC Filings data provided by Edgar Online Inc..
    Earnings data provided by FactSet CallStreet, LLC.
    Home | Contact Us | Advertise with Us | Corrections | Career Opportunities | Site Map
    RSS | Email Delivery | Portfolio | Podcasts | Mobile | Widgets | User Preferences | Special Sections
    | Magazine Customer Service | Download Fortune Lists | Reprints | Conferences | Business Leader Council
    graphic